Sixth Street Growth

Sixth Street Growth operates as a distinct investment vertical within Sixth Street, which also runs credit, venture, and public equity strategies. The growth team has its own deal-sourcing and execution autonomy, but can access the firm's total capital base for follow-on rounds and co-investments. This structure allows Sixth Street Growth to provide portfolio companies with both growth capital and potential liquidity via Sixth Street's public-market expertise.

The group concentrates on technology and healthcare services. In technology, it targets enterprise software, fintech, and AI/ML companies. In healthcare, it invests in digital health, benefits administration, and life sciences tools. The firm explicitly avoids energy, real estate, and hard-asset investments, per its published materials.

Yes, as a lead or co-lead growth-equity investor, Sixth Street Growth regularly secures board observer or director positions. This is standard practice across its portfolio, especially in deals where it commits $100M+ and holds a meaningful ownership stake. Board involvement gives the firm monitoring rights and influence over strategic decisions.

Sixth Street Growth invests between $50M and $500M per deal, targeting Series C through pre-IPO rounds. It occasionally participates in crossover rounds alongside public-market investors. The firm prefers companies with $50M+ in annual recurring revenue (ARR) and clear acceleration to profitability, per multiple transaction reports.

The growth platform is managed by a team of partners, including John Sill, who transferred from Sixth Street's technology vertical. The firm does not publicly identify a single CEO or CIO for the growth unit; investment decisions are made by committee within the vertical, with final approval from Sixth Street's executive committee for large commitments.

Sixth Street Growth leverages the broader Sixth Street network — including relationships with corporate partners, bankers, and portfolio companies from its credit and venture arms. It also runs a small internal team dedicated to direct sourcing via industry conferences, management introductions, and inbound referrals from its existing LP base, which includes institutional investors like endowments and pension funds.

Yes, but its primary focus is North America. Occasional deals in Europe and Asia occur, typically in technology companies with strong US expansion plans. The firm does not have dedicated regional offices outside the US, and international investments are led by the same sector-specialist teams based in San Francisco.